Differential Urinary Proteomic Analysis of Endometrial Cancer

Area of Science:

• Gynecological Oncology
• Proteomics
• Biomarker Discovery

Background:

• Endometrial cancer is a frequent gynecological malignancy, but current screening methods are costly and lack sensitivity.
• Early diagnosis is crucial for improving patient outcomes.
• There is a significant need for effective, accessible screening tools for endometrial cancer.

Purpose of the Study:

• To investigate the potential of urinary proteomics for identifying early diagnostic and screening biomarkers for endometrial cancer.
• To analyze semi-quantitative changes in the urinary proteome of patients with endometrial cancer.

Main Methods:

• A bottom-up proteomic approach utilizing nano HPLC-ESI-MS/MS was applied to analyze urine samples.
• Patients with endometrial cancer were compared to a control group.

Main Results:

• Significant semi-quantitative changes were observed in the urinary proteome of patients with endometrial cancer.
• Proteins such as cadherin-1 (CDH1), vitronectin (VTN), and HSPG2 were found to be down-regulated compared to controls.
• These proteins may play a role in the pathogenesis of endometrial cancer.

Conclusions:

• Urinary proteomics demonstrates potential for discovering novel cancer protein biomarkers.
• Altered protein concentrations in urine can serve as indicators for endometrial cancer.
• This approach may lead to the development of effective screening tests for early detection.